PREGENEN
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs. They work with our partners to apply their tools, services and reagents to increase the reliability, efficacy and safety of a new wave of therapies harnessing the specificity and functional power of molecules and cells produced by the body.
PREGENEN
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.pregenen.com
Status:
Closed
Contact:
2065452897
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Nginx Baidu Analytics
Similar Organizations
Abound Bio
Abound Bio specializes in generating antibody-based biological therapeutics to meet medical needs in the fields of cancer.
Kintara Therapeutics
Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
More informations about "Pregenen"
Pregene
普瑞金致力于研发国人用得起的生物药，专注于细胞与基因治疗药物的研发与推广，荣获广东省细胞与基因治疗创新药物工程技术研究中心，更是中国car-t药物质量标准制定的参与单位，部分技术居于世界先进水平。See details»
Pregene - Crunchbase Company Profile & Funding
Organization. Pregene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Pregene is a drug and nano-antibody drug biotechnology research and development platform. ...See details»
About Us - Pregene
Pregene focuses on the R&D of cell and gene therapy drugs and has achieved phased R&D results. For BCMA-targeted CAR-T cell agent for the treatment of multiple myeloma, the Company obtained an NMPA clinical approval letter in …See details»
Shenzhen Pregene Biopharma Co., Ltd-Pregene
Shenzhen Pregene Biopharma Co., Ltd. (874090) is a national high-tech enterprise with the mission of “Developing urgently needed cell and gene therapy drugs for clinical treatment”. Its product pipelines include CAR-T and CAR-NK …See details»
Pregene Company Profile 2024: Valuation, Funding
Pregene General Information Description. Developer and manufacturer of biological drugs designed for the treatment of leukemia and malignant lymphoma. The company has a biopharmaceutical research and development platform …See details»
Pregenen - Crunchbase Company Profile & Funding
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs. They work with our partners to apply their tools, services and reagents …See details»
Pregene - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 3, 2018: Series A - …See details»
Pregene Biotechnology Company Profile 2024: …
Pregene Biotechnology General Information Description. Developer, producer and seller of molecular diagnostic kits and supporting instruments. The company develops ultra-multiplex PCR technology, droplet generation technology, …See details»
Pregenen - LinkedIn
Pregenen | 207 followers on LinkedIn. Exciting news (see attached Press Release), as Pregenen has been acquired by bluebird bio, Inc. (Nasdaq: BLUE), a public gene therapy company …See details»
Press Release | Pregene be Listed as Shenzhen …
Pregene has completed a series of process development for multiple cutting-edge projects such as universal CAR-T, dual-target CAR-T, TCR-T, mRNA, and stem cells. Other product pipelines for cancer, autoimmune diseases and other …See details»
Pregene - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Pregene is actively using 17 technologies for its website, according to BuiltWith. These include Viewport Meta , IPhone / Mobile Compatible , and SPF . Website Tech Stack by BuiltWithSee details»
Pregene Enters into Innovative Partnership with CellPoint to …
Apr 6, 2022 Pregene is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies with industry-leading cell and lentivirus manufacturing …See details»
Pregene and CellPoint to develop cell therapy for haematological ...
Apr 7, 2022 As per the deal, Pregene is eligible for an upfront payment of more than $22m (€20m) and near-term consideration from CellPoint. Pregene is also entitled to receive further …See details»
Latest news-Pregene
Shenzhen Pregene Obtained the Clinical Implied License for the Anti-BCMA CAR-T Drug from NMPA with the Support from Lewwin... Read More. 05. 2020. 03. Shenzhen Pregene …See details»
Ribrecabtagene autoleucel - Drug Targets, Indications, Patents
Shenzhen Pregene Biopharma, a clinical-stage biopharmaceutical company engaged in discovering, developing, manufacturing and commercializes innovative medicines and …See details»
Pregene - Updates, News, Events, Signals & Triggers - Crunchbase
Pregene is a drug and nano-antibody drug biotechnology research and development platform.See details»
Technology-Pregene
Pregene screened a number of high-affinity and high-specificity nanobodies through a self-built high-throughput nanobody screening platform and built core products: For CAR-T cell agents …See details»
Pregene - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Pregene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Pregene has 1 …See details»
Pregene Enters into Innovative Partnership with CellPoint to …
Apr 6, 2022 In May of 2021, Pregene and Dr. Reddy's Laboratories announced a license agreement whereby Dr Reddy's acquired the exclusive rights in India for PRG-1801. Clinical …See details»
Pregene and Dr. Reddy's Announce License Agreement for Anti …
Pregene's product pipeline includes various cell therapy programs under development for the treatment of hematological malignancies, solid tumors and bone defects. About Dr. Reddy's …See details»